Endocyte Announces First Quarter 2018 Earnings Call
WEST LAFAYETTE, Ind., May 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company will host a conference call on Wednesday, …